Aadi Bioscience (FRA:3350) EPS (Basic) : €-2.36 (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience EPS (Basic)?

Aadi Bioscience's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was €-0.63. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.36.

Aadi Bioscience's EPS (Diluted) for the three months ended in Mar. 2024 was €-0.63. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.36.

Aadi Bioscience's EPS without NRI for the three months ended in Mar. 2024 was €-0.63. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was -2.36.

During the past 3 years, the average EPS without NRI Growth Rate was -144.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Aadi Bioscience's highest 3-Year average EPS without NRI Growth Rate was -144.50% per year. The lowest was -144.50% per year. And the median was -144.50% per year.

Aadi Bioscience EPS (Basic) Historical Data

The historical data trend for Aadi Bioscience's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience EPS (Basic) Chart

Aadi Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

-0.18

-10.98

-2.54

-2.24

Aadi Bioscience Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial										-0.53	-0.62	-0.56	-0.55	-0.63

Aadi Bioscience EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Aadi Bioscience's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-60.307	-	0)	/	26.918
	=	-2.24

Aadi Bioscience's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-16.826	-	0)	/	26.981
	=	-0.62

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.36

Aadi Bioscience (FRA:3350) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Aadi Bioscience EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Aadi Bioscience (FRA:3350) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

AADI:USA 3350:Germany

Address

17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272

Website

https://www.aadibio.com

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (FRA:3350) Headlines

No Headlines